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8R-Lipoxygenase and allene oxide synthase (AOS) are parts of a
naturally occurring fusion protein from the coral Plexaura homo-
malla. AOS catalyses the production of an unstable epoxide (an
allene oxide) from the fatty acid hydroperoxide generated by the
lipoxygenase activity. Here, we report the structure of the AOS
domain and its striking structural homology to catalase. Whereas
nominal sequence identity between the enzymes had been previ-
ously described, the extent of structural homology observed was
not anticipated, given that this enzyme activity had been exclu-
sively associated with the P450 superfamily, and conservation of a
catalase fold without catalase activity is unprecedented. Whereas
the heme environment is largely conserved, the AOS heme is
planar and the distal histidine is flanked by two hydrogen-bonding
residues. These critical differences likely facilitate the switch from
a catalatic activity to that of a fatty acid hydroperoxidase.
eicosanoids  heme
The occurrence of prostaglandins and other eicosanoids insoft corals such as the Caribbean gorgonian Plexaura homo-
malla has stimulated many investigations on the pathways of
their biosynthesis. The prostaglandins are formed from arachi-
donic acid via a conventional cyclooxygenase route (1, 2), yet the
overwhelming catalytic activity evident in coral extracts is li-
poxygenase (LOX) pathway metabolism (3). Arachidonic acid is
converted to an 8R-hydroperoxide that is further transformed to
an allene oxide (epoxide) (3–5). This pathway bears many
parallels with the route of jasmonic acid biosynthesis in plants
(Fig. 1) (6). In corals, subsequent steps may lead to cyclic
products such as the clavulones (4, 7), although this connection
remains to be proven.
In the course of their efforts to elucidate eicosanoid biosyn-
thetic pathways in coral, Brash and coworkers (8) identified a
gene coding for a 122-kDa fusion protein that includes both LOX
and allene oxide synthase (AOS) domains. The C-terminal
79-kDa domain of the fusion protein, an 8R-LOX, is similar to
mammalian LOXs in size, sequence, and substrate specificity; its
closest homologue (40% sequence identity) in mammals is
5-LOX, an enzyme responsible for the synthesis of leukotrienes
from arachidonic acid (9). The N-terminal 43-kDa AOS domain
of the fusion protein uses the 8R-hydroperoxide as its preferred
substrate (10). This hemoprotein domain has weak sequence
identity to catalase (11% amino acid identity) with five regions
of homology identified, all of which involve heme-binding or
catalytic residues (8). Spectroscopic data (e.g., electron para-
magnetic resonance, UV-vis, and magnetic CD) indicated that
AOS, like catalase, is a heme protein with a tyrosine axial ligand
(11). However, AOS is without catalase activity because it does
not catalyze the dismutation of hydrogen peroxide to water (10).
The sequences of plant AOSs clearly establish the enzymes as
members of the cytochrome P450 superfamily. Plant AOSs are
members of a subfamily of the fatty acid hydroperoxide-
metabolizing P450s designated as CYP74A (12). Other classes of
P450 enzymes, such as mammalian prostacyclin synthase and
thromboxane synthase, also catalyze similar chemistry on fatty
acid peroxides (13). The coral AOS, with its sequence and
spectral relationship to catalases, is, therefore, quite exceptional.
Catalases are not recognized for an involvement in biosynthesis
(14). Given that there is no precedent for a catalase-like fold in
which catalatic activity is replaced completely by a biosynthetic
activity, we determined the crystal structure of the AOS domain
of the naturally occurring fusion protein to elucidate the features
of this distinctive enzyme.
Methods
Expression and Purification. AOS fused to a C-terminal 4 His tag
was overexpressed in BL21(DE3) cells. Cells were pelleted (at
5,000  g for 20 min at 4°C), frozen at 80°C, and subsequently
resuspended in Bugbuster lysis buffer (Novagen) in the presence
of protease inhibitors (PMSF, leupeptin, and pepstatin A) and
DNase I. After sonication of the cells and removal of debris by
centrifugation (at 46,000  g for 20 min at 4°C), the supernatant
was applied to a nickel nitrilotriacetic acid agarose (Qiagen,
Valencia, CA) preequilibrated with 20 mM imidazole and 500
mM NaCl. Protein was eluted with 200 mM imidazole. Further
purification was accomplished with ion exchange and gel filtra-
tion chromatography [DE52, Sephacryl S300, and mono-Q
(Pharmacia, Uppsala)] to yield pure protein (100 mgliter of
culture) that displayed the characteristic ratio of A406A280 of
1.8, which is consistent with full heme occupancy as previously
determined (11). All chromatographic procedures were buffered
with 10 mM TrisHCl, pH 8.0.
Crystallization. Initial screens were performed at 4°C and 22°C
with commercial (Hampton Research and Emerald Biostruc-
tures) and in-house (ammonium sulfate, pentaerythritol
propoxylates, and ethoxylates) screens. In addition, the publicly
available microbatch screening services of the Hauptman–
Woodward Institute in Buffalo, NY were used. Although crystals
were obtained in four distinct space groups, only those that
belong to the monoclinic space group C2 (a  147.9 Å, b  76.7
Å, c  77.8 Å,   109.7°) proved useful for structure deter-
mination. These thin, plate-like crystals grow in hanging-drop
setups from 100 mM BisTrisHCl, pH 5.7, 16% polyethylene
glycol MME 5000 and diffract to 2-Å resolution on a rotating
anode.
Data Collection and Phasing. Heavy-atom data were collected at
100 K on a Nonius FR591 rotating anode fitted with a Mar165
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image plate detector. Fe-multiwavelength anomalous dispersion
(Fe-MAD) data at 100 K were collected at the protein crystal-
lography beamline at the Center for Advanced Microstructures
and Devices at Louisiana State University, with a Mar charge-
coupled device camera. Data processing and scaling were per-
formed by using DENZO (15). The structure was solved by
combining phase information derived from MAD and multiple
isomorphous replacement data sets (Tables 1 and 2 ). The 4.0-Å
resolution anomalous difference Patterson calculated from Fe-
MAD data revealed clear peaks attributable to the heme iron,
and these positions were refined with 2.2-Å data in CNS (16). The
hand of the Fe positions was determined by calculation of
heavy-atom difference Fourier maps with diffraction data from
AuCl3- (1 mM for 1 h) and K2PtBr4 (1 mM for 24 h)-soaked
crystals. For both heavy-atom data sets, obtained to resolutions
of 3.6 and 3.8 Å, respectively, clear peaks were visible with only
the original hand assigned to the Fe atom, and these positions
were compatible with those determined from heavy-atom dif-
ference Patterson maps. Approximately 80% of the backbone
was traceable in a 3.4-Å resolution solvent-f lattened map cal-
culated after combination of the heavy atom and MAD phases.
The extent of the model and resolution of the maps were
extended over several cycles of model building. The final model
at 2.0-Å resolution (two molecules in the asymmetric unit, 5,964
protein atoms, 86 cofactor atoms, and 569 water molecules) has
an RworkRfree of 19.624.0, with no  cutoffs applied. A repre-
sentative 2 Fo  Fc electron density map contoured at 1.5 is
shown in Fig. 2a.
Results
The monomer of AOS is a wedge-shaped protein with all three
dimensions 45–50 Å. The enzyme has an  fold composed
of an eight-stranded antiparallel -barrel, located at one of the
vertices of the wedge, and 13 -helices (Fig. 2b). Of the 373 aa
in the expressed protein, all but the first two (as well as the 4
His purification tag) and the last five are visible in the final
electron density map. In the crystal, monomers associate by
means of a parallel interaction of the 3 helices (Fig. 2c). This
dimerization motif is observed in all four crystal forms (orthor-
hombic, triclinic, monoclinic, and C-centered monoclinic; data
not shown). At the N termini of the associating helices, extensive
contacts are made through hydrophobic amino acids (F37, L40,
and L44), whereas at the C termini, intermolecular contacts
involve the packing of threonines (T51, T54, and T58) in a
fashion reminiscent of a leucine zipper. The oligomeric interface
(1,070 Å2 per monomer) is localized on one edge of the
wedge-shaped molecule, resulting in an overall bow-tie-shaped
dimer.
Fig. 1. Comparison of allene oxide biosynthesis in coral and plants. The
conversion of allene oxide to clavulone remains unproven.
Table I. Data collection
Data collection
Fe-MAD MIR
Native Peak Inflection Remote AuCl3 K2PtBr4
Space group C2
Cell
a, Å 147.9 148.0 151.9 151.5
b, Å 76.7 76.8 79.8 79.3
c, Å 77.8 78.0 77.2 77.6
, ° 109.7 109.8 110.6 111.0
Resolution range, Å 50–2.0 50–2.3 50–2.2 50–2.2 30–3.6 30–3.8
Unique reflections 55,410 71,477 81,796 80,984 9,115 9,970
Completeness* 100.0 (100.0) 99.9 (99.6) 99.9 (99.8) 99.2 (97.4) 97.5 (98.8)
Redundancy 5.8 3.4 3.4 3.6 4.8 5.9
I 21.5(3.7) 13.5 (3.1) 13.3 (2.7) 15.7 (4.1) 16.8 (2.6) 13.2 (3.6)
Rsym,† % 8.2 (36.2) 9.3 (38.5) 9.4 (39.4) 8.5 (29.5) 8.2 (42.5) 11.0 (43.1)
MIR, multiple isomorphous replacement.
*Values in parentheses are for the highest-resolution shell.
†Rsym  ¥ Ii  I¥ Ii, where Ii is the intensity of the ith observation and I is the mean intensity of the reflection.




































In contrast to typical heme proteins, the prosthetic group in
AOS is remarkably planar. The heme is centered in the mono-
mer, positioned between one side of the -barrel and helices 4
and 13. On the proximal side of the heme Y353, provided by
13, fills one of the axial sites for the Fe, whereas a large cavity
flanked by loops 64–67, 105–108, and turn 156–158 allows access
to the remaining axial position (the distal) where the tetrapyr-
role ring forms the base of a U-shaped substrate-binding pocket
(Fig. 2d). The outside edge of the pocket (13 Å from the heme
Fe) is lined with basic residues (K107 and K60) that form a
positively charged ridge flanked by 3. The interior region of the
pocket is lined with hydrophobic residues (F153 and F241, V156,
L106, L176, and L190). The propionic acid groups of the heme
form salt bridges with three arginine residues (R64, R102, and
R360). The penta-coordinated active-site Fe is positioned 2.0 Å
from the pyrole nitrogens of the heme and 2.15 Å from the
oxygen provided by Y353. Electron density attributed to water
molecules is 2.85 Å from the heme Fe on the distal side. H67
is positioned slightly above this density, f lanked by hydrogen-
bonding residues N137 and T66 (Fig. 2a).
Discussion
AOS Resembles a Catalase Core. Although a catalase-like structure
had been predicted for AOS, the extent of the structural
similarity is striking (rms deviation of 1.65 Å for 225 of 373 Cs),
because even with the aid of a structure-based sequence align-
ment the sequence identity between human erythrocyte catalase
Fig. 2. The structure of the coral AOS. (a) Stereo image of representative 2 Fo Fc electron density map of the active site contoured at 1.5. Distal-side residues
(T66, H67, and N137) and proximal-side residues (R349 and Y353) are shown for reference. (This figure and all other structural renderings were created by using
PYMOL, which can be accessed at www.pymol.org.) (b) Stereo image of coral AOS backbone trace: -sheets, -strands, coiled regions, and heme groups are red,
yellow, green, and blue, respectively. (c) The dimer interface formed by 3 of the two molecules in the asymmetric unit. Residues that line the interface are drawn
in a stick format. (d) Sectioned view of the solvent-accessible surface of the substrate-binding pocket. Basic residues at the opening of the cavity (K60 and K107)
and active-site residues (T66, H67, N137, and Y353) are indicated.
Table 2. Refinement statistics
Rwork, % 19.6
Rfree,* % 24.0




rms deviation from ideality
Bond lengths, Å 0.0058
Bond angles, ° 1.35






*R  ¥Fo  Fc¥Fo, where Fo and Fc are the observed and calculated
structure factors amplitudes. Rfree is calculated by using 5% of the total
reflections.











































(HEC) and AOS is only 11% for 300 aa. The two enzymes
share similar placement of 7 of the 10 -strands and 7 of the 13
-helices found in AOS (Fig. 3). AOS appears to be a catalase
‘‘core’’ in which the eight-stranded -barrel and the majority of
the helical domain are maintained, whereas the N-terminal
threading arm and the C-terminal wrapping domain, parts of the
catalase structure important for tetramerization, are discarded.
AOS has no sequence similarity to catalases in its N terminus and
ends before the formation of a wrapping domain. AOS and
catalase do use a similarly positioned helix to form an oligomeric
interface, although in AOS the helices remain associated with
their respective monomers, and are not ‘‘domain-swapped,’’ as
they are in catalase tetramers. It is noteworthy that the place-
ment of the elements of secondary structures containing the
three arginines that neutralize the heme carboxylates, and the
residues adjacent to the proximal and distal sides of the heme is
preserved. In a context of minimal sequence identity, the
conservation of the heme environment and the heme protein
hydrogen-bonding network is striking (Fig. 3b): the notable
differences are the substitution of Val with Thr (T66 and AOS),
displacement of N137 relative to its counterpart in catalase, and
the substitution of His with Val (V196).
The AOS Structure Is Consistent with Spectroscopic Data. The AOS
crystal structure clearly supports the results of earlier spectro-
scopic studies that compared AOS to HEC and indicated a
tyrosine-ligated penta-coordinated ferric heme group with a
vacant sixth position (11). In contrast, plant AOS as a P450 uses
a cysteinate axial ligand. The mirror image Soret CD spectra of
AOS and HEC are explained by the heme group being flipped
in AOS with respect to its orientation in the catalase: AOS heme
has a His-III and HEC a His-IV orientation. This terminology
refers to which ring of the porphyrin lies below the distal
histidine. The ‘‘f lipped’’ orientation is observed in other cata-
lases, e.g., CatF from Pseudomonas syringae (17), and there is
some evidence to suggest that this His-IV orientation is associ-
ated with the evolutionary earliest catalases (14).
The Chemical Nature of the U-Shaped Cavity Is Complementary to the
Substrate. AOS has converted the catalase H2O2 selectivity
channel to a fatty acid binding pocket. In the catalase tetramer,
funnel-shaped tunnels of 30 Å are lined with phenylalanine
residues and end with a narrow constriction to aid in the
selection of H2O2. In AOS, the entrance to the cavity is positively
charged and the distance to the heme is significantly shorter
(13 Å). The size of the binding pocket (1,150 Å3) as
calculated with the CASTP server (18) is similar to those described
for other eicosanoid binding proteins {e.g., rabbit reticulocyte
15S-LOX [Protein Data Bank (PDB) ID code 1LOX], PPAR
(PDB ID code 1PRG), and adipocyte lipid-binding protein
(PDB ID code 1ADL)}. The dimensions and chemical nature of
the U-shaped binding pocket are consistent with 8R-
hydroperoxyeicosatetraenoic acid binding with its carboxylate
tail at the mouth of the cavity, presumably neutralized with a salt
bridge to either K107 or K60. Either residue could position C8
of the substrate in suitable proximity to H67, N137, and the
penta-coordinated Fe. The hydrophobic residues lining the
pocket provide for extensive protein-substrate van der Waals
interaction.
The large substrate binding cavity of AOS appears to expose
the heme to small pseudosubstrates and inhibitors. However,
Abraham et al. (11) reported that both azide or cyanide,
inhibitors of catalase because they are able to fill the open sixth
coordination position of the heme Fe, have significantly reduced
affinity (500-fold) for the heme in AOS. In catalase, these
inhibitors are positioned to coordinate the heme Fe with hy-
drogen bonds to the distal His (azide, ref. 19), or a water
molecule positioned by its hydrogen bond to the distal His
(cyanide, ref. 20). In AOS, the distal His (H67) is f lanked by T66
Fig. 3. Comparison of AOS and catalase. (a) Superimposition of AOS (green;
heme is red) with HEC (gray; heme is blue). The catalase N-terminal threading
arm and wrapping domains are indicated. (b) Superposition of the heme
environments of AOS (green carbons) and catalase (gray carbons). Dashed
lines indicating active-site hydrogen bonds are black (AOS) and pink (HEC),
respectively.
Fig. 4. Proposed reaction scheme for coral AOS. H67 hydrogen bonds to the
terminal peroxide oxygen, favoring homolytic cleavage. This process results in
formation of an alkoxyl radical, then a carbon radical, and, ultimately, a
short-lived epoxy allylic carbocation that is deprotonated to form the allene
oxide. The carbon radical formed reduces Fe-IV and the carbocation produced
is eliminated by the removal of a proton by H67.




































and N137 and fixed by hydrogen bonds to both of these amino
acids, and is thus unable to mediate binding of the inhibitors.
This arrangement of the active site appears to limit the approach
to an otherwise accessible heme by potential pseudosubstrates.
AOS promotes 1,400 turnovers s1, and the enzyme is deac-
tivated in 1 min at room temperature (10). This deactivation
has been attributed to off-pathway heterolytic cleavage of the
peroxide bond (21). Catalases have turnover numbers from
54,000 to 833,000 s1 (22), whereas no catalase activity is
detected with AOS at enzyme concentrations 100 times those
needed to produce a signal for the reaction with 8R-
hydroperoxyeicosatetraenoic acid, and deactivation of AOS
occurs with only with a 10-fold excess of H2O2 over the course
of 1.5 h (21). Thus, despite a large substrate access cavity that
cannot exclude the approach of H2O2 to the heme, AOS does not
have catalatic activity, nor is it rapidly deactivated by hydrogen
peroxide.
The Adaptation of a Catalase to an AOS. Whereas AOS and catalase
both perform cleavage of a peroxide bond, in the former one of
the oxygens remains associated with the substrate in an epoxide,
whereas in the latter a two-step process that requires the
production of a heme species known as compound I results in
the formation of water and molecular oxygen. The two steps of
the catalase reaction are as follows: (i) A hydrogen peroxide
molecule oxidizes the heme to an oxyferryl species in which one
oxidant equivalent is removed from the iron and one from the
porphyrin ring to form the intermediate known as compound I,
and (ii) a second hydrogen peroxide molecule is used as a
reductant of compound I to regenerate the resting state of the
enzyme. The first step of the reaction, the heterolytic cleavage
of the peroxide bond that yields the compound I intermediate,
can be trapped upon reaction with the substrate analog peracetic
acid. In contrast, the reaction of AOS with peracetic acid
produces compound I as a transient intermediate on a deacti-
vation pathway: electron paramagnetic resonance studies sug-
gest that the unpaired electron of compound I is rapidly (1 s)
transferred to a Tyr residue (21). While in catalase, the enzyme-
compound I intermediate can be maintained for 30 min (e.g.,
ref. 23).
How is the adaptation of catalase, an enzyme that catalyzes
heterolysis of the peroxide bond and requires the formation of
an oxyferryl intermediate, to an AOS that catalyzes homolytic
cleavage of the peroxide without compound I formation, ac-
complished? There are three possible factors that may contrib-
ute to this fundamental difference in catalytic mechanisms: the
heme environment, heme conformation, and the nature of the
substrate and its fit into the binding site. As can be seen from Fig.
3b, the heme environments are strikingly conserved. Both
catalase and AOS have similarly positioned arginines at the
heme propionic acid groups (R64, R102, and R360 in AOS, and
R72, R112, and R365 in HEC) and the proximal Tyr (R349 in
AOS and R354 in HEC). Guallar et al. (24) have suggested that
charged residues near the heme propionic acids attenuate the
properties of the prosthetic group. However, the only difference
here is that in HEC H362 is hydrogen bonded to a propionic acid
group, whereas in AOS it is Q195. This difference is not likely
to be significant because Gln is found at this position in catalases
as well. Similarly, the Arg-proximal Tyr interaction has been
proposed to be important for compound I formation because it
‘‘tunes’’ the heme so that oxidation occurs on the porphoryin
ring (25). Whereas both enzymes have this interaction, in
catalase the Arg participates in a hydrogen bond with a histidine
residue that is replaced by a Val in AOS. Perhaps a deprotonated
highly conserved histidine helps stabilize the compound I inter-
mediate of catalase by dissipating the charge–charge repulsion
between the Arg and the pi-cation radical.
An additional distinctive feature of AOS (vs. catalases and
heme enzymes in general) is the planarity of its heme. It is the
protein environment surrounding the heme that determines the
extent of prosthetic group distortion that is conserved among
members of a given superfamily (26). Quantitation of deviation
from planarity of the heme by the method developed by Shellnut
et al. (27) gives a value for the total out-of-plane distortion for
the AOS heme of 0.11 Å, a number within the coordinate error
for the structure determination. In contrast, the same value for
HEC, a structure determined to 1.5-Å resolution, is 0.72 Å.
Studies with synthetic hemes have shown that nonplanar heme
groups are more easily oxidized than their planar counterparts
(28), and the nonplanarity can affect not only the site of
oxidation (metal or ring) but also the type of oxidation (two
electrons vs. one electron) (29). Because distortion of heme
planarity is energetically unfavorable (30), the difference in AOS
and catalase heme shape is likely necessary for the difference in
redox properties. In catalase, the nonplanar heme is oxidized
with a two-electron oxidation removing electrons from the Fe
and the porphyrin ring in the formation of compound I. As
revealed by crystallographic studies, this transition involves the
movement of the Fe out of the plane of the heme in the direction
of the distal histidine, and the oxygen of the proximal Tyr to
which it is bound shifts as well (23). The planarity of the AOS
heme would make such a conformational change, the displace-
ment of the Fe out of the plane of the heme unfavorable, and
thus serve as a barrier for the formation of a catalase-like
compound I species. This feature is of critical importance given
that compound I formation is not productive in the ultimate
formation of the allene oxide product, but also without the aid
of an additional reductant (H2O2 in catalase) a compound I form
of AOS leads to its inactivation (21). Another factor that may
correlate with heme chemistry is the Fe-axial ligand distance,
which is longer in AOS than it is in catalase structures: 2.15
(AOS) vs. 1.84 Å (HEC).
The fatty acid hydroperoxide substrate itself may play a role
in the fact that cleavage of the peroxide bond proceeds through
homolytic rather than heterolytic cleavage because (i) the con-
jugated diene structure can stabilize the free radical product of
homolytic cleavage, and (ii) the large bulky substrate fills the
pocket, and there is no room for water to promote heterolytic
cleavage by protonation of the leaving group. In their studies
with P450s, Correia et al. (31) found that with smaller substrates
the ratio of hetero- to homolytic cleavage products increased, an
observation attributed to the fact that the smaller substrates do
not exclude water from the enzyme active site.
We propose that in AOS, minor modifications to the heme
environment promote homolytic bond cleavage (Fig. 4), and thus
the generation of a free radical intermediate, in a mechanism
akin to that of plant AOSs that are P450 enzymes (12). As in
catalase, the distal histidine (H67) hydrogen bonds to the
peroxide group of the fatty acid substrate, whereas N137 (or
T66) forms a hydrogen bond with the distal oxygen of the
peroxide. Homolysis of the peroxide bond produces an alkoxyl
radical that rearranges to a carbon radical, and ultimately a
short-lived epoxy allylic carbocation that is deprotonated by H67
to form the allene oxide. The carbon radical formed reduces
Fe-IV and the carbocation produced is eliminated by the re-
moval of a proton by H67. The planarity of the heme, a barrier
to the formation of a compound I intermediate, and the exclu-
sion of water from the binding site facilitate the switch from a
catalase to an AOS.
AOS Is Found in a Naturally Occurring Fusion Protein. As noted
earlier, the coral AOS occurs as the N-terminal domain of a
fusion protein with a C-terminal domain of 8R-LOX. Covalent
fusion of the AOS and LOX should greatly enhance any mutual
affinity of the two domains by increasing their effective concen-
trations, facilitating rapid transfer of the labile 8R-hydroperox-











































ide from the LOX to the AOS active site. In an evolutionary
context, Eisenberg and coworkers (32) noted that when two
interacting proteins are fused, successive mutations will even-
tually create an optimized protein–protein interface, which,
accordingly is to be anticipated for the AOS-LOX fusion protein.
Marcotte et al. (32) suggest that the existence of a fusion
protein in the genome of one species could be used to infer
protein–protein interactions in homologues in other species
where the two proteins are expressed separately. The fusion of
AOS to LOX in coral, therefore, may be indicative of catalase-
related AOS homologues interacting with LOX in other organ-
isms. By analogy to the plant CYP74 P450 family that metabolize
fatty acid hydroperoxides, such homologues could exhibit AOS,
hydroperoxide lyase, epoxyalcohol synthase, or divinyl ether
synthase activities (6). Whether residing in fusion proteins or as
autonomous polypeptides, 8R-LOX and AOS activities are
ubiquitous in corals (5, 33, 34), and their expression will likely be
detected in other invertebrates (35). Other homologues of the
AOS domain suggest expanded roles. One such homolog from
cyanobacteria is a hypothetical protein of 773 residues (30%
identity to coral AOS in 373 residues) that also contains a
domain of 400 residues with significant identity to LOXs (36).
Other potential matches are a domain in a 2,391-residue protein
from the rice genome (28% identity for 301 of 373 residues) (37),
and a short catalase-related protein of 378 residues in the wheat
blight fungus Fusarium graminearum that resides in the genome
next to a putative LOX. Thus, catalase-like AOS enzymes are
likely to have diverse roles in eicosanoid biosynthesis.
Concluding Remarks. Coral AOS comprises a catalase-like core
with minor active site alterations that confer AOS activity.
Adaptation of catalase to a biosynthetic enzyme is accom-
plished primarily with surprisingly modest changes in the
immediate heme environment in the context of only 11%
sequence identity. Another eicosanoid biosynthetic enzyme
has been described that represents similarly an adapted en-
zyme: leukotriene A4 hydrolase is a modified zinc peptidase
with structural homology to thermolysin (38). Leukotriene A4
hydrolase retains the catalytic activity of the progenitor en-
zyme and is a peptidase as well as a hydrolase, whereas AOS
represents a complete switch from a H2O2-metabolizing cata-
lase to a biosynthetic fatty acid hydroperoxidase.
We thank Henry Bellamy for assistance at the Center for Advanced
Microstructures and Devices PX beamline, William Boeglin for assis-
tance in construct design and expression, and M. Graça Vicente for
insights into heme chemistry. This work was supported in part by
National Institutes of Health Grants GM 55420 (to M.E.N.) and
GM 53638 (to A.R.B.) and the Louisiana Governor’s Biotechnology
Initiative.
1. Valmsen, K., Jarving, I., Boeglin, W. E., Varvas, K., Koljak, R., Pehk, T., Brash,
A. R. & Samel, N. (2001) Proc. Natl. Acad. Sci. USA 98, 7700–7705.
2. Valmsen, K., Boeglin, W. E., Jarving, I., Schneider, C., Varvas, K., Brash, A. R.
& Samel, N. (2004) Eur. J. Biochem. 271, 3533–3538.
3. Brash, A. R., Baertschi, S. W., Ingram, C. D. & Harris, T. M. (1987) J. Biol.
Chem. 262, 15829–15839.
4. Corey, E. J., d’Alarcao, M., Matsuda, S. P. T., Lansbury, P. T. & Yamada, Y.
(1987) J. Am. Chem. Soc. 109, 289–290.
5. Corey, E. J., Matsuda, S. P. T., Nagata, R. & Cleaver, M. B. (1988) Tetrahedron
Lett. 29, 2555–2558.
6. Feussner, I. & Wasternack, C. (2002) Annu. Rev. Plant Biol. 53, 275–297.
7. Grechkin, A. N. (1995) J. Lipid. Mediat. Cell Signal. 11, 205–218.
8. Koljak, R., Boutaud, O., Shieh, B. H., Samel, N. & Brash, A. R. (1997) Science
277, 1994–1996.
9. Werz, O. (2002) Curr. Drug Targets Inflamm. Allergy 1, 23–44.
10. Boutaud, O. & Brash, A. R. (1999) J. Biol. Chem. 274, 33764–33770.
11. Abraham, B. D., Sono, M., Boutaud, O., Shriner, A., Dawson, J. H., Brash,
A. R. & Gaffney, B. J. (2001) Biochemistry 40, 2251–2259.
12. Song, W. C., Funk, C. D. & Brash, A. R. (1993) Proc. Natl. Acad. Sci. USA 90,
8519–8523.
13. Tanabe, T. & Ullrich, V. (1995) J. Lipid. Mediat. Cell Signal. 12, 243–255.
14. Chelikani, P., Fita, I. & Loewen, P. C. (2004) Cell Mol. Life Sci. 61, 192–208.
15. Otwinowski, Z. & Minor, W. (1997) Methods Enzymol. 276, 307–326.
16. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P.,
Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S.,
et al. (1998) Acta Crystallogr. D 54, 905–921.
17. Carpena, X., Soriano, M., Klotz, M. G., Duckworth, H. W., Donald, L. J.,
Melik-Adamyan, W., Fita, I. & Loewen, P. C. (2003) Proteins 50, 423–436.
18. Liang, J., Edelsbrunner, H. & Woodward, C. (1998) Protein Sci. 7, 1884–1897.
19. Mate, M. J., Zamocky, M., Nykyri, L. M., Herzog, C., Alzari, P. M., Betzel, C.,
Koller, F. & Fita, I. (1999) J. Mol. Biol. 286, 135–149.
20. Putnam, C. D., Arvai, A. S., Bourne, Y. & Tainer, J. A. (2000) J. Mol. Biol. 296,
295–309.
21. Wu, F., Katsir, L. J., Seavy, M. & Gaffney, B. J. (2003) Biochemistry 42,
6871–6880.
22. Switala, J. & Loewen, P. C. (2002) Arch. Biochem. Biophys. 401, 145–154.
23. Gouet, P., Jouve, H. M., Williams, P. A., Andersson, I., Andreoletti, P.,
Nussaume, L. & Hajdu, J. (1996) Nat. Struct. Biol. 3, 951–956.
24. Guallar, V., Baik, M. H., Lippard, S. J. & Friesner, R. A. (2003) Proc. Natl.
Acad. Sci. USA 100, 6998–7002.
25. Green, M. T. (2001) J. Am. Chem. Soc. 123, 9218–9219.
26. Jentzen, W., Ma, J. G. & Shelnutt, J. A. (1998) Biophys. J. 74, 753–763.
27. Shelnutt, J. A., Song, X.Z., Ma, J. G., Jia, S. L., Jentzen, W. & Medforth, C. J.
(1998) Chem. Soc. Rev. 27, 31–41.
28. Ravikanth, M. & Chandrashekar, T. K. (1995) Coord. Chem. 82, 105–188.
29. Kadish, K. M., Vancaemelbecke, E., Dsouza, F., Medforth, C. J., Smith, K. M.,
Tabard, A. & Guilard, R. (1995) Inorg. Chem. 34, 2984–2989.
30. Anderson, K. K., Hobbs, J. D., Luo, L. A., Stanley, K. D., Quirke, J. M. E. &
Shelnutt, J. A. (1993) J. Am. Chem. Soc. 115, 12346–12352.
31. Correia, M. A., Yao, K., Allentoff, A. J., Wrighton, S. A. & Thompson, J. A.
(1995) Arch. Biochem. Biophys. 317, 471–478.
32. Marcotte, E. M., Pellegrini, M., Ng, H. L., Rice, D. W., Yeates, T. O. &
Eisenberg, D. (1999) Science 285, 751–753.
33. Corey, E. J., Lansbury, P. T. & Yamada, Y. (1985) Tetrahedron Lett. 26,
4171–4174.
34. Varvas, K., Jarving, I., Koljak, R., Valmsen, K., Brash, A. R. & Samel, N. (1999)
J. Biol. Chem. 274, 9923–9929.
35. Brash, A. R., Hughes, M. A., Hawkins, D. J., Boeglin, W. E., Song, W. C. &
Meijer, L. (1991) J. Biol. Chem. 266, 22926–22931.
36. Kaneko, T., Nakamura, Y., Wolk, C. P., Kuritz, T., Sasamoto, S., Watanabe,
A., Iriguchi, M., Ishikawa, A., Kawashima, K., Kimura, T., et al. (2001) DNA
Res. 8, 205–213, 227–253.
37. Feng, Q., Zhang, Y. J., Hao, P., Wang, S. Y., Fu, G., Huang, Y. C., Li, Y., Zhu,
J. J., Liu, Y., Hu, X., et. al. (2002) Nature 420, 316–320.
38. Rudberg, P. C., Tholander, F., Thunnissen, M. M. & Haeggstrom, J. Z. (2002)
J. Biol. Chem. 277, 1398–1404.
302  www.pnas.orgcgidoi10.1073pnas.0406352102 Oldham et al.
D
ow
nl
oa
de
d 
at
 T
R
O
Y
 H
 M
ID
D
LE
T
O
N
 L
IB
R
A
R
Y
 o
n 
O
ct
ob
er
 6
, 2
02
1 
